Hospital News and Research

RSS

Viral load peaks in early stages of COVID-19, study shows

In a retrospective study, investigators from New York University Langone Health found that the quantity of SARS-CoV-2 (viral load) collected from patients in the emergency department is significantly higher in patients with fewer or milder symptoms who did not require hospitalization--the opposite of what might be expected.

15 Jul 2020

Umbilical cord blood treats children born with non-cancerous genetic disorders

Researchers at UPMC Children's Hospital of Pittsburgh found that infusing umbilical cord blood -- a readily available source of stem cells -- safely and effectively treated 44 children born with various non-cancerous genetic disorders, including sickle cell, thalassemia, Hunter syndrome, Krabbe disease, metachromatic leukodystrophy (MLD) and an array of immune deficiencies.

15 Jul 2020

HLA-G gene linked to male-to-female ratio at birth, survival of fetuses, and preeclampsia

Preeclampsia is globally a leading cause of illness and deaths among mothers and their babies. This severe pregnancy disorder occurs in up to five percent of all pregnancies.

15 Jul 2020

Fewer but larger doses of radiotherapy are safe for patients with early breast cancer

A lower total dose of radiotherapy delivered in fewer but larger doses is as safe in the long term as breast cancer radiotherapy courses giving multiple small doses, according to the final results of a 10-year study.

15 Jul 2020

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One in four new leukemia cases are CLL.

15 Jul 2020

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19.

15 Jul 2020

PET radiotracer is safe and effective for imaging malignant brain tumors

A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas.

14 Jul 2020

Nano-radiomics uses imaging data to assess changes in the tumor microenvironment

Research has shown that the tumor microenvironment (TME) can help cancers grow and evade the immune response.The TME has even been shown to inhibit cellular immunotherapy, a novel form of treatment in which the cells of a patient's immune system are re-engineered in the lab to attack cancer cells.

14 Jul 2020

PET reveals the existence of inter-organ communication between the heart and kidneys after heart attack

Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction, or heart attack.

14 Jul 2020

Study estimates the cost-effectiveness of esketamine used for treating depression

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use.

14 Jul 2020

A mobile platform for screening lung cancer

A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher, according to study published today in The Annals of Thoracic Surgery.

14 Jul 2020

The immune system can play a key role in improving recovery from heart attacks

International research collaboration to pioneer the field of immuno-cardiology and investigate ways to harness the power of the immune system to improve recovery from heart attacks will be led at the Perelman School of Medicine at the University of Pennsylvania by Jonathan Epstein, MD, executive vice dean, chief scientific officer and the William Wikoff Smith Professor of Cardiovascular Research.

14 Jul 2020

UTHealth physicians study blood pressure drug's efficiency in improving COVID-19 outcomes

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston.

14 Jul 2020

Beta blockers can increase risk of heart failure in women more than men

Women taking beta blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospital with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal.

14 Jul 2020

Study shows gut microbiota can predict the development of type 2 diabetes

The individual mix of microorganisms in the human gastrointestinal tract provides vital clues as to how any future incidence of type 2 diabetes can be predicted, prevented and treated. This is demonstrated in a population study led from the University of Gothenburg. Sweden.

14 Jul 2020

New technology can improve treatment for cystic fibrosis

World-first research led by Monash University could hold the key to better monitoring and treatment of lung disease associated with cystic fibrosis (CF) - a condition thousands of people are diagnosed with each year.

14 Jul 2020

Single dose of tocilizumab improves survival in critically ill COVID-19 patients

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to a new study by a team from the University of Michigan.

14 Jul 2020

Hospital News and Research

Viral load peaks in early stages of COVID-19, study shows

Umbilical cord blood treats children born with non-cancerous genetic disorders

HLA-G gene linked to male-to-female ratio at birth, survival of fetuses, and preeclampsia

Fewer but larger doses of radiotherapy are safe for patients with early breast cancer

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

Keck Medicine of USC participates in clinical trial to test antiviral drug as potential COVID-19 treatment

PET radiotracer is safe and effective for imaging malignant brain tumors

Nano-radiomics uses imaging data to assess changes in the tumor microenvironment

PET reveals the existence of inter-organ communication between the heart and kidneys after heart attack

Study estimates the cost-effectiveness of esketamine used for treating depression

A mobile platform for screening lung cancer

The immune system can play a key role in improving recovery from heart attacks

UTHealth physicians study blood pressure drug's efficiency in improving COVID-19 outcomes

Beta blockers can increase risk of heart failure in women more than men

Study shows gut microbiota can predict the development of type 2 diabetes

New technology can improve treatment for cystic fibrosis

Single dose of tocilizumab improves survival in critically ill COVID-19 patients

New technology generates immune response by delivering antigens to APCs in the spleen

Study calls for alternative options to clean disposable surgical masks

Genomics study in Black Americans could lead to precision prostate cancer therapies

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics